Genfit Sa share price logo

Genfit Sa Share Price

NASDAQ: GNFT

Small Cap

$4.25

as on

Genfit Sa Stock Performance

as on October 14, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $4.19
    $4.22
    downward going graph

    1.41%

    Downside

    -0.71%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.55
    $6.42
    downward going graph

    40.00%

    Downside

    51.13%

    Upside

    downward going graph

Genfit Sa share price movements today

Previous Close
$4.25
Open
$4.19
Volume
13.1K
Day's Low - High
$4.19 - $4.22
52 Week Low - High
$2.55 - $6.42

Genfit Sa Historical Returns

1 Month Return
+ 0.05 %
3 Month Return
+ 12.14 %
1 Year Return
-30.44 %
3 Year Return
+ 5.2 %
5 Year Return
-3.19 %

Genfit Sa Stock Fundamentals & Key Indicators

Check Genfit Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$223.1M

EPS (TTM)

-0.185

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-26.4M

Revenue (TTM)

45.1M

Profit Margin

-85.89%

Return On Equity TTM

55600.00%

Genfit Sa vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Genfit Sa with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Genfit Sa image
Genfit Sa
BUY$223.1M-3.19%NA-85.89%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.3B223.08%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.8BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$104.6B50.07%28.9831.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.8B-7.17%14.2331.37%

Stock Returns calculator for Genfit Sa Stock including INR - Dollar returns

The Genfit Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Genfit Sa investment value today

Current value as on today

₹75,164

Returns

₹24,836

(-24.84%)

Returns from Genfit Sa Stock

₹30,442 (-30.44%)

Dollar Returns*

₹5,606 (+5.61%)

Analyst Recommendation on Genfit Sa Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Genfit Sa. Average target price of $7.4

Genfit Sa Share Price Target

Get share price movements and forecasts by analysts on Genfit Sa.

What analysts predicted

42.57%UPSIDE

Target Price

$7.4

Current Price

$4.25

Analyzed by

13 Analysts

Target

$7.40

Genfit Sa target price $7.4, a slight upside of 42.57% compared to current price of $4.25. According to 13 analysts rating.

Genfit Sa Stock’s Investor Sentiment and Interest

Search interest for Genfit Sa Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-10% versus previous 30 day period

Genfit Sa Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Total Revenue
5
6
8
12
3
15
15
65
8
5
Gross Profit
5
6
8
16
3
21
21
65
-
6
Operating Income
5
6
-9
-23
2
5
-2
31
-31
-27
EBITDA
5
-13
-9
-19
2
-7
-10
32
-24
-24
Interest Expense
-
2
2
2
-
3
2
2
2
2
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-6
-16
-10
-23
-4
-8
-4
30
-28
-28
Income Tax Expense
0
-2
0
-3
0
0
3
0
0
0
Net Income
-6
-14
-11
-22
-4
-8
-8
32
-28
-28
Net Profit Margin
-125.42%
-218.54%
-138.01%
-181.62%
-142.65%
-56.36%
-56.36%
49.61%
-358.75%
-488.20%

Genfit Sa Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
0
34
0
90
21
31
70
Gross Profit
-1
-1
-2
-2
34
0
90
21
30
69
Operating Income
-17
-34
-56
-69
-57
-82
31
-27
-26
3
EBITDA
-17
-33
-55
-68
-51
-73
34
-25
-22
8
Interest Expense
-
0
2
10
11
11
4
4
4
4
Depreciation
-
-
1
1
3
3
2
1
1
1
Income Before Tax
-17
-33
-58
-79
-65
-101
69
-23
-28
1
Income Tax Expense
0
0
0
0
0
0
2
0
0
0
Net Income
-18
-35
-69
-90
-72
-123
76
-25
-31
1
Net Profit Margin
-3251.42%
-11854.58%
-49664.41%
-115247.83%
-211.24%
-13231.50%
84.00%
-117.45%
-101.15%
2.25%

Genfit Sa Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Net Income
-13
-10
-20
-4
-8
-28
30
-28
-28
Operating Cash Flow
-26
-12
-25
-15
-30
-30
-11
26
26
Investing Cash Flow
-46
1
2
0
0
0
0
0
0
Financing Cash Flow
0
0
0
-1
-3
-3
-4
-6
-6
Change in Cash
-73
-12
-24
-111
-34
-34
61
-
-61

Genfit Sa Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-33
-58
-79
-65
-101
67
-23
-28
1
Operating Cash Flow
-27
-49
-56
-47
-96
99
-72
-55
15
Investing Cash Flow
-2
-2
-3
0
0
-3
-46
2
-1
Financing Cash Flow
121
174
-6
116
-8
-8
-3
-5
-10
Change in Cash
92
121
-66
69
-105
87
-122
-58
3

Global Institutional Holdings in Genfit Sa

Funds
Holdings
Morgan Stanley - Brokerage Accounts
0.05%
Citadel Advisors Llc
0.04%
Optiver Holding B.V.
0.01%
UBS Group AG
0.01%
Advisor Group Holdings, Inc.
0%
See all

Insights on Genfit Sa

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GNFT stock has moved up by 7.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 143.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.5% return, outperforming this stock by 92.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 61.10M → 5.9M (in $), with an average decrease of 56.7% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 30.31M → -28.80M (in $), with an average decrease of 97.5% per quarter

About Genfit Sa

genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver (such as nash - nonalcoholic steatohepatitis) or the bowel (such as the inflammatory bowel disease). genfit is committed to contribute to bringing new medicines to market for patients who lack suitable solutions, and strives to implement mutually beneficial approaches that combine novel drugs and biomarkers. its research programs have resulted in the creation of a rich and diversified pipeline of drug candidates, including genfit’s lead proprietary compound, gft505, that is completing a phase 2b study in nash.
OrganisationGenfit Sa
HeadquartersParc EurasantE, Loos, France, 59120
IndustryBiotechnology
CEOMr. M. Pascal Prigent
E-voting on sharesClick here to vote

Key Management of Genfit Sa

Name

Title

Ms. Stefanie Magner J.D.

Chief Compliance Officer & Executive VP of International Legal Affairs

Mr. Jean-Francois Mouney

Co-Founder & Chairman of the Board

Ms. Sakina Sayah-Jeanne

Chief Scientific Officer, Executive VP of Research & Translational Science

Mr. Laurent Lannoo

Corporate Secretary & Director of Legal Affairs

Mr. Pascal Caisey

Chief Operating Officer

Mr. Jean-Christophe Marcoux

Chief Corporate Affairs Officer, Head of Investor Relations & Head of ESG

Ms. Emilie Desodt

Executive Vice President of Human Resources

Mr. M. Pascal Prigent

Chief Executive Officer

Prof. Bart Staels

Co-Founder & Chairman of the Scientific Advisory Board

Mr. Thomas Baetz

Chief Financial Officer

FAQs

What is Genfit Sa share price today?

Genfit Sa share price today is $4.25 as on at the close of the market. Genfit Sa share today touched a day high of $4.22 and a low of $4.19.

What is the 52 week high and 52 week low for Genfit Sa share?

Genfit Sa share touched a 52 week high of $6.42 on and a 52 week low of $2.55 on . Genfit Sa stock price today i.e. is closed at $4.25,which is 33.83% down from its 52 week high and 66.67% up from its 52 week low.

What is Genfit Sa's market capitalisation today?

Genfit Sa market capitalisation is $0.00T as on .

How to invest in Genfit Sa Stock (GNFT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Genfit Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genfit Sa Shares that will get you 0.3529 shares as per Genfit Sa share price of $4.25 per share as on October 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Genfit Sa Stock (GNFT) from India?

Indian investors can start investing in Genfit Sa (GNFT) shares with as little as ₹88.635 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Genfit Sa stock (as per the Rupee-Dollar exchange rate as on ). Based on Genfit Sa share’s latest price of $4.25 as on October 14, 2025 at 1:29 am IST, you will get 2.3529 shares of Genfit Sa. Learn more about fractional shares .

What are the returns that Genfit Sa has given to Indian investors in the last 5 years?

Genfit Sa stock has given -3.19% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?